SYK vs VRTX: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

SYK
STRYKER CORP
BUY
86%
Confidence
VS
VRTX
VERTEX PHARMACEUTICALS INC / MA
BUY
86%
Confidence

SYK vs VRTX Fundamental Comparison

Metric SYK VRTX
Revenue $25.1B $12.0B
Net Income $3.2B $4.0B
Net Margin 12.9% 32.9%
ROE 14.5% 21.2%
ROA 6.8% 15.4%
Current Ratio 1.89x 2.90x
Debt/Equity 0.66x 0.01x
EPS $8.40 $15.32

Green = Better metric | Red = Weaker metric

View Full SYK Analysis →
View Full VRTX Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

SYK vs AAPL VRTX vs MSFT SYK vs GOOGL VRTX vs AMZN

SYK vs VRTX: Frequently Asked Questions

Is SYK or VRTX a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. SYK is rated BUY (86% confidence) while VRTX is rated BUY (86% confidence). This is not investment advice.

How does SYK compare to VRTX fundamentally?

STRYKER CORP has ROE of 14.5% vs VERTEX PHARMACEUTICALS INC / MA's 21.2%. Net margins are 12.9% vs 32.9% respectively.

Which stock pays higher dividends, SYK or VRTX?

SYK has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in SYK or VRTX for long term?

For long-term investing, consider that SYK has BUY rating with 86% confidence, while VRTX has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about SYK vs VRTX?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SYK vs VRTX, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.